Company / SG&A per Share
LEXICON PHARMACEUTICALS, INC. SG&A per Share History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.31
FY2025
5-year range
$0.22 / $0.45
FY2021-FY2025
Trend
+8.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $0.03 in FY2014 to $0.45 in FY2019.
Based on SEC 10-K filings.
0.31 in FY2025 with a 10-year CAGR of +3.0%.
Increased from $0.22 to $0.31 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +3.0%
Key checks
Key Insights
- In FY2025, sg&a per share increased 8.2% year-over-year.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.31 | +8.2% |
| FY2024 | $0.29 | +30.7% |
| FY2023 | $0.22 | -50.3% |
| FY2019 | $0.45 | +7.6% |
| FY2018 | $0.42 | +80.6% |
| FY2017 | $0.23 | -9.5% |
| FY2016 | $0.25 | +8.9% |
| FY2015 | $0.23 | +571.1% |
| FY2014 | $0.03 | -31.6% |
| FY2013 | $0.05 | -20.5% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026